Nebulized particles for allergic rhinitis with asthma
Part of Ear, nose & throat, Immune system & allergy, Lungs & breathing clinical trials.
This study tests an inhaled mist made from tiny particles that may reduce allergy and asthma symptoms. It might help people whose current allergy medicines are not working well enough.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 60 years old.
- You have moderate to severe allergic rhinitis (hay fever) and also have asthma.
- Your allergies and asthma have not been well controlled by your current allergy medicines for the past year.
- You are not doing allergy shots or immunotherapy, or that treatment has not worked for you.
- If you are a woman who can have children, you must agree to use birth control during the study and for 30 days after.
- You are able to give informed consent and follow the study schedule.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 study tests a “viral” treatment meant to reprogram the lining of your nose to reduce allergy-like immune responses. It is testing whether this approach is safe and can help people with cat allergy (with or without asthma) or compare against healthy people.
This trial tests whether a seawater nasal spray can relieve nasal congestion, runny nose, and other sinus symptoms in people with colds, allergies, or after nose surgery. You will use the spray as directed and answer online questionnaires for up to 3 months.
This study looks at blood and other measures (biomarkers) to understand how well mepolizumab helps people with nasal polyps, with or without asthma. It aims to find response clues that could help personalize treatment in the future.
This study tests a new type of treatment using a mist (nebulized) made from stem cell byproducts to see if it can safely help people with a rare autoimmune lung disease. It is for patients with anti-MDA5 positive dermatomyositis who have a fast-progressing lung condition.
This trial tests whether a nasal spray made from stem cell particles can help people recover after an ischemic stroke. It is for adults who had a stroke within the last two weeks and did not receive clot-busting treatment.
This study tests an experimental treatment using tiny particles from human stem cells, given through a nebulizer (breathing mist). It aims to see if this treatment is safe and can help improve lung function in people with interstitial lung disease (lung scarring).
Hear when a new Allergic Rhinitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.